Cardiological Optimization in Compensated Right Ventricular Failure with Pulmonary Hypertension Perioperatively
Patients with compensated RV failure and pulmonary hypertension undergoing surgery must have their PAH-specific medications continued without interruption throughout the perioperative period, be managed at centers with pulmonary hypertension expertise, and have optimization completed before any elective procedure. 1
Preoperative Optimization
Mandatory Requirements Before Surgery
- Continue all PAH-specific therapies without interruption for preoperative fasting—convert to intravenous or nebulized formulations temporarily if oral absorption is compromised 1
- Optimize treatment regimen before any non-emergency surgical intervention at a specialized center 1
- Multidisciplinary planning by the pulmonary hypertension team for high-risk patients is essential 1
Risk Stratification to Guide Decision-Making
Surgery should be avoided unless absolutely necessary given the 38% perioperative cardiopulmonary complication rate and 7% mortality 1. Poor prognostic factors include:
- NYHA functional class >III
- Significant RV dysfunction on imaging
- Intermediate to high-risk surgery
- Long duration of anesthesia 1
Intraoperative Management
Critical Physiologic Targets
Avoid four key triggers that increase pulmonary vascular resistance and precipitate RV failure:
Hypoxemia - Alveolar hypoxia causes pulmonary vasoconstriction; maintain normoxic ventilation 2
Acidosis (both respiratory and metabolic) - Increases PVR and potentiates hypoxic vasoconstriction; aim for alkalotic pH range to decrease RV afterload 2
Volume overload - Avoid RV overfilling which creates a downward spiral of RV failure 2
Elevated intrathoracic pressure - Directly increases PVR; minimize positive pressure ventilation when possible 2
Specific Interventions for RV Support
Inhaled pulmonary vasodilators (Class IIa recommendation):
- Inhaled nitric oxide OR inhaled epoprostenol can lower PVR by 25% without affecting systemic vascular resistance 2
- Both agents are equally effective; use continuously during general anesthesia to replace patient-delivered therapies 2, 3
Cardiac pacing optimization:
- Atrial or AV sequential pacing is superior to isolated RV pacing - RV pacing alone lowers cardiac output by approximately 20% 2
- Consider biventricular pacing if prolonged QRS is present 2
Volume management:
- Use invasive monitoring (arterial line, central venous catheter, consider PA catheter) to guide precise fluid administration 2, 4, 5
- Judicious volume for hypovolemia; diuretics for overload 2
Postoperative Management
Monitoring Requirements
Mandatory intensive monitoring for at least 24 hours postoperatively in a unit with appropriate expertise 1. The highest mortality occurs in the postoperative period 1.
Management of Postoperative RV Failure Progression
If RV failure worsens postoperatively, implement this escalating approach:
Optimize diuretic dosing to reduce RV preload 1
Initiate inotropic support with dobutamine under guidance of a physician experienced in PAH management 1, 4
Continue inhaled pulmonary vasodilators (nitric oxide or epoprostenol) 2
Maintain the four critical physiologic targets listed above 2
Consider VA-ECMO if respiratory insufficiency develops with significant RV failure, as permissive hypercapnia causes respiratory acidosis that worsens RV afterload 2
Critical Pitfalls to Avoid
- Never withhold PAH-specific medications for fasting or NPO status 1
- Do not start new PAH therapies in the perioperative period—this has not been established as safe or effective 1
- Avoid isolated RV pacing if pacing is required 2
- Do not permit permissive hypercapnia without recognizing it will worsen RV function through respiratory acidosis 2
The evidence strongly supports that elective surgery should be delayed until optimization is complete at an expert center, as outcomes are significantly worse when these patients undergo procedures at non-specialized facilities 1.